Becker's Healthcare November 23, 2022
Molly Gamble

Mark Cuban is in talks with hospitals to identify generic drugs that often run in short supply, which he aims to make in a robotics-driven manufacturing plant currently in development in Dallas.

Mr. Cuban appeared on the Motley Fool podcast Nov. 23 with host Chris Hill to talk about disrupting healthcare, which Cost Plus Drugs has managed to do since its establishment in May 2020. The company’s portfolio now has nearly 1,000 generics, which are sold with a 15 percent markup for price, a $3 pharmacy fee to pay the pharmacists it works with and a $5 fee for shipping.

Mr. Cuban shared his plans for the $11 million Dallas manufacturing plant on the Motley Fool podcast with Mr....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Pharma, Pharma / Biotech, Provider
Will The White House’s Plan To Curb Drug Shortages Work?
Pharma Pulse 4/24/24: 5 Things You Should Know About Women's Health, Microsoft Makes Push Into Smaller AI Systems & more
New AI drug discovery powerhouse Xaira rises with $1B in funding
AI-enabled drug discovery company Xaira launches with $1B
25 most expensive hospital drugs

Share This Article